FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

SUPPL AP for TIVICAY (DOLUTEGRAVIR SODIUM)